{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:51:24Z","timestamp":1790257884811,"version":"4.1.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Transplant."],"abstract":"<jats:p>Achieving long-term allograft survival while minimizing systemic immunosuppression (IS) remains a critical unmet need in transplantation. While adaptive immunity has traditionally been the primary focus of IS therapy, innate immune cells\u2014that include neutrophils, monocytes, macrophages, dendritic cells, myeloid-derived suppressor cells, innate lymphoid cells (ILCs), natural killer (NK) cells, and gamma delta (\u03b3\u03b4) T cells act as key upstream orchestrators of allograft rejection and tolerance. Recent advances in single-cell RNA sequencing and spatial transcriptomics have unveiled the profound heterogeneity of these cell populations, identifying distinct regulatory subsets and novel inhibitory checkpoints. These high-resolution insights provide the scientific rationale for developing innovative precision therapies that can selectively modulate innate immune reactivity without compromising global immunity. Here, we review innovative strategies to target\/amplify these mechanisms, including targeting the myeloid inhibitory checkpoints (e.g., leukocyte immunoglobulin-like receptor B; sialic acid-binding immunoglobulin-like lectin-E) to induce tolerogenic phenotypes. We further discuss the modulation of metabolic reprogramming to prevent \u201ctrained immunity\u201d using mammalian target of rapamycin inhibitor (mTORi)-loaded nanoparticles, and the use of CRISPR (clustered regularly interspaced short palindromic repeats)\/Cas9 gene editing to silence T cell costimulatory signals. We evaluate the adoptive transfer of regulatory myeloid cells, -specifically donor-derived regulatory macrophages and regulatory dendritic cells, and innate lymphoid cells in transplant recipients. Furthermore, the potential of targeting specific NK cell and ILC subsets associated with graft regulation is addressed. Collectively, these emerging approaches aim to reprogram the allograft microenvironment, offering a promising paradigm shift towards establishing transplant tolerance.<\/jats:p>","DOI":"10.3389\/frtra.2026.1776806","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T07:29:18Z","timestamp":1770622158000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Innovative approaches targeting innate immune cells to promote organ transplant tolerance"],"prefix":"10.3389","volume":"5","author":[{"given":"Chiyoshi","family":"Toyama","sequence":"first","affiliation":[{"name":"Department of Surgery , Thomas E . Starzl Transplantation Institute","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[{"name":"Department of Surgery , Thomas E . Starzl Transplantation Institute","place":["Pittsburgh, PA, United States"]},{"name":"Department of Immunology, University of Pittsburgh School of Medicine","place":["Pittsburgh, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"B1","volume-title":"Immunosuppressive Drugs: Developments in Anti-Rejection Therapy","author":"Thomson","year":"1994"},{"key":"B2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nm1251","article-title":"Organ transplantation\u2014how much of the promise has been realized?","volume":"11","author":"Lechler","year":"2005","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/lt.22265","article-title":"Operational tolerance: past lessons and future prospects","volume":"17","author":"Levitsky","year":"2011","journal-title":"Liver Transplant"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.01044","article-title":"Transplant tolerance induction: insights from the liver","volume":"11","author":"Dai","year":"2020","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/med\/9780197697320.001.0001","volume-title":"Long-Term Care of Kidney Transplant Patients","author":"Hariharan","year":"2024"},{"key":"B6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/ajt.14436","article-title":"Innate allorecognition by monocytic cells and its role in graft rejection","volume":"18","author":"Lakkis","year":"2018","journal-title":"Am J Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.aax4040","article-title":"PIRs mediate innate myeloid cell memory to nonself MHC molecules","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.ajt.2025.06.030","article-title":"Sensitization in transplantation assessment of risk 2025 innate working group: the potential role of innate allorecognition in kidney allograft damage","volume":"25","author":"Thaunat","year":"2025","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1111\/ajt.12799","article-title":"Adenosine triphosphate-competitive mTOR inhibitors: a new class of immunosuppressive agents that inhibit allograft rejection","volume":"14","author":"Rosborough","year":"2014","journal-title":"Am J Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/tri.13504","article-title":"Tolerogenic dendritic cells in organ transplantation","volume":"33","author":"Ochando","year":"2020","journal-title":"Transpl Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.01454","article-title":"The role of natural killer cells in the immune response in kidney transplantation","volume":"11","author":"Pontrelli","year":"2020","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/cei\/uxad050","article-title":"Protective and pathogenic functions of innate lymphoid cells in transplantation","volume":"213","author":"Mak","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"eaam6202","DOI":"10.1126\/sciimmunol.aam6202","article-title":"Donor SIRP polymorphism modulates the innate immune response to allogeneic grafts","volume":"2","author":"Dai","year":"2017","journal-title":"Sci Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.ady1135","article-title":"Donor-recipient mismatch at the SIRPA locus adversely affects kidney allograft outcomes","volume":"17","author":"Zhao","year":"2025","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e128014","DOI":"10.1172\/jci.insight.128014","article-title":"Landscape of innate immune system transcriptome and acute T cell\u2013mediated rejection of human kidney allografts","volume":"4","author":"Mueller","year":"2019","journal-title":"JCI Insight"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e21294","DOI":"10.1002\/advs.202521294","article-title":"A subset of pro-inflammatory CXCL10+ LILRB2+ macrophages derives from recipient monocytes and drives renal allograft rejection","volume":"9","author":"Varin","year":"2026","journal-title":"Adv Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"eads2694","DOI":"10.1126\/scitranslmed.ads2694","article-title":"The inhibitory receptor siglec-E controls antigen-presenting cell activation and T cell-mediated transplant rejection","volume":"17","author":"Borges","year":"2025","journal-title":"Sci Transl Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s40472-016-0126-5","article-title":"Notch signaling and immune regulation in alloimmunity","volume":"3","author":"Murakami","year":"2016","journal-title":"Curr Transplant Reports"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1097\/TP.0000000000001468","article-title":"Notch signaling and alloreactivity","volume":"100","author":"Radojcic","year":"2016","journal-title":"Transplantation"},{"key":"B21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCULATIONAHA.119.040563","article-title":"Notch-1 inhibition promotes immune regulation in transplantation via regulatory T cell-dependent mechanisms","volume":"140","author":"Magee","year":"2019","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1146\/annurev-immunol-090419-020340","article-title":"Immunology in the era of single-cell technologies","volume":"38","author":"Efremova","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41592-022-01409-2","article-title":"Museum of spatial transcriptomics","volume":"19","author":"Moses","year":"2022","journal-title":"Nat Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1067512","DOI":"10.3389\/frtra.2023.1067512","article-title":"Innate immune cellular therapeutics in transplantation","volume":"2","author":"Ott","year":"2023","journal-title":"Front Transplant"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-39859-7","article-title":"Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection","volume":"14","author":"Lamarth\u00e9e","year":"2023","journal-title":"Nat Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/s41591-025-03568-z","article-title":"LILRB3 Genetic variation is associated with kidney transplant failure in African American recipients","volume":"31","author":"Sun","year":"2025","journal-title":"Nat Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e141593","DOI":"10.1172\/jci.insight.141593","article-title":"LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation","volume":"5","author":"Yeboah","year":"2020","journal-title":"JCI Insight"},{"key":"B28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","article-title":"Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance","volume":"49","author":"Braza","year":"2018","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.abe7853","article-title":"A modular approach toward producing nanotherapeutics targeting the innate immune system","volume":"7","author":"van Leent","year":"2021","journal-title":"Sci Adv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"119302","DOI":"10.1016\/j.biomaterials.2019.119302","article-title":"In situ repurposing of dendritic cells with CRISPR\/Cas9-based nanomedicine to induce transplant tolerance","volume":"217","author":"Zhang","year":"2019","journal-title":"Biomaterials"},{"key":"B31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/tri.12889","article-title":"Tolerogenic dendritic cell therapy in organ transplantation","volume":"30","author":"Moreau","year":"2017","journal-title":"Transpl Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.4049\/JIMMUNOL.1100762","article-title":"Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients","volume":"187","author":"Hutchinson","year":"2011","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/acssynbio.4c00589","article-title":"Advances in engineering myeloid cells for cell therapy applications","volume":"14","author":"Freitas","year":"2025","journal-title":"ACS Synth Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-025-01380-w","article-title":"Neutrophils as critical orchestrators of chronic inflammation","author":"Torfs","year":"2026","journal-title":"Cell Mol Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/ajt.13940","article-title":"The role of neutrophils in transplanted organs","volume":"17","author":"Scozzi","year":"2017","journal-title":"Am J Transplant"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.823511","article-title":"Neutrophil extracellular traps regulate HMGB1 translocation and kupffer cell M1 polarization during acute liver transplantation rejection","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"114763","DOI":"10.1016\/j.intimp.2025.114763","article-title":"Neutrophil extracellular traps activate STING signaling to promote dendritic cell-driven rejection after liver transplantation","volume":"160","author":"Wang","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3724\/abbs.2024055","article-title":"Salidroside ameliorates acute liver transplantation rejection in rats by inhibiting neutrophil extracellular trap formation","volume":"56","author":"Qin","year":"2024","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1681\/asn.20233411s123a","article-title":"The alteration of monocyte subsets and the early acute rejection after kidney transplantation","volume":"34","author":"Song","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.4049\/jimmunol.2300625","article-title":"Tissue-resident macrophages in solid organ transplantation: harmful or protective?","volume":"212","author":"Aiello","year":"2024","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"eadd1967","DOI":"10.1126\/sciimmunol.add1967","article-title":"Resident tissue macrophages: key coordinators of tissue homeostasis beyond immunity","volume":"9","author":"Zhao","year":"2024","journal-title":"Sci Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/MOT.0000000000000209","article-title":"The divergent roles of macrophages in solid organ transplantation","volume":"20","author":"Salehi","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"B44","doi-asserted-by":"publisher","first-page":"107322","DOI":"10.1016\/j.intimp.2020.107322","article-title":"The characteristics of regulatory macrophages and their roles in transplantation","volume":"91","author":"Zhang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/xen.12326","article-title":"Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s)","volume":"24","author":"Guo","year":"2017","journal-title":"Xenotransplantation"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2016.00087","article-title":"Transplantation tolerance induction: cell therapies and their mechanisms","volume":"7","author":"Scalea","year":"2016","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-05167-8","article-title":"TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity","volume":"9","author":"Riquelme","year":"2018","journal-title":"Nat Commun"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2015.05.009","article-title":"DC-SIGN+ macrophages control the induction of transplantation tolerance","volume":"42","author":"Conde","year":"2015","journal-title":"Immunity"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s41590-021-01045-6","article-title":"Epithelial cells remove precancerous cells by cell competition via MHC class I\u2013LILRB3 interaction","volume":"22","author":"Ayukawa","year":"2021","journal-title":"Nat Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/ti.2024.12995","article-title":"The potential role of the leucocyte immunoglobulin-like receptors in kidney transplant rejection: a Mini review","volume":"37","author":"Palvair","year":"2024","journal-title":"Transpl Int"},{"key":"B51","doi-asserted-by":"publisher","first-page":"101559","DOI":"10.1016\/j.trim.2022.101559","article-title":"Effect of a C5a receptor antagonist on macrophage function in an intestinal transplant rat model","volume":"72","author":"Toyama","year":"2022","journal-title":"Transpl Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1432-2277.2008.00680.x","article-title":"Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation","volume":"21","author":"Hutchinson","year":"2008","journal-title":"Transpl Int"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1111\/ajt.16393","article-title":"Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients","volume":"21","author":"Macedo","year":"2021","journal-title":"Am J Transplant"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (the ONE study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1432-2277.2008.00692.x","article-title":"A cell-based approach to the minimization of immunosuppression in renal transplantation","volume":"21","author":"Hutchinson","year":"2008","journal-title":"Transpl Int"},{"key":"B56","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity\u2014basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/ajt.14645","article-title":"Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance","volume":"18","author":"Braza","year":"2018","journal-title":"Am J Transplant"},{"key":"B60","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1084\/jem.20082394","article-title":"Constitutive ablation of dendritic cells breaks self-tolerance of CD4T cells and results in spontaneous fatal autoimmunity","volume":"206","author":"Ohnmacht","year":"2009","journal-title":"J Exp Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"157970","DOI":"10.3390\/ijms22157970","article-title":"Regulatory macrophages and tolerogenic dendritic cells in myeloid regulatory cell-based therapies","volume":"22","author":"Suuring","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"63343","DOI":"10.3389\/fimmu.2021.633436","article-title":"Regulatory dendritic cells, T cell tolerance, and dendritic cell therapy for immunologic disease","volume":"12","author":"Ness","year":"2021","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imr.70073","article-title":"Dendritic cells: orchestrators of immune responsiveness and tolerance","volume":"336","author":"Polonio","year":"2025","journal-title":"Immunol Rev"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.cmet.2019.11.011","article-title":"Human tolerogenic dendritic cells regulate immune responses through lactate synthesis","volume":"30","author":"Marin","year":"2019","journal-title":"Cell Metab"},{"key":"B65","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri1256","article-title":"Dendritic cells: emerging pharmacological targets of immunosuppressive drugs","volume":"4","author":"Hackstein","year":"2004","journal-title":"Nat Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/761429","article-title":"Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation","volume":"2013","author":"Vassalli","year":"2013","journal-title":"J Transplant"},{"key":"B67","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/MOT.0000000000000097","article-title":"Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells","volume":"19","author":"Morelli","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"B68","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1182\/blood-2012-08-449983","article-title":"Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b b2-integrin-dependent signaling","volume":"121","author":"McMillan","year":"2013","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jcyt.2022.11.005","article-title":"Manufacturing and validation of good manufacturing practice\u2013compliant regulatory dendritic cells for infusion into organ transplant recipients","volume":"25","author":"Zahorchak","year":"2023","journal-title":"Cytotherapy"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/ajt.12310","article-title":"Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates","volume":"13","author":"Ezzelarab","year":"2013","journal-title":"Am J Transplant"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.adf4287","article-title":"Donor-derived regulatory dendritic cell infusion modulates effector CD8+ T cell and NK cell responses after liver transplantation","volume":"15","author":"Tran","year":"2023","journal-title":"Sci Transl Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/cts.13208","article-title":"Natural killer cells in liver transplantation: can we harness the power of the immune checkpoint to promote tolerance?","volume":"15","author":"Halma","year":"2022","journal-title":"Clin Transl Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e185687","DOI":"10.1172\/jci.insight.185687","article-title":"High-dimensional analysis of NK cells in kidney transplantation uncovers subsets associated with antibody-independent graft dysfunction","volume":"9","author":"Ruan","year":"2024","journal-title":"JCI Insight"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e137047","DOI":"10.1172\/JCI137047","article-title":"Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury","volume":"131","author":"Calabrese","year":"2021","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.ajt.2025.04.024","article-title":"Alloreactive adaptive natural killer cells in renal transplantation: potential contribution to allograft microvascular inflammation","volume":"25","author":"Alari-Pahissa","year":"2025","journal-title":"Am J Transplant"},{"key":"B77","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1056\/nejmoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01721","article-title":"Broad impairment of natural killer cells from operationally tolerant kidney transplanted patients","volume":"8","author":"Dugast","year":"2017","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"100723","DOI":"10.1016\/J.TRRE.2022.100723","article-title":"Natural killer cells and killer cell immunoglobulin-like receptors in solid organ transplantation: protectors or opponents?","volume":"36","author":"Zamir","year":"2022","journal-title":"Transplant Rev"},{"key":"B80","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12026-023-09421-0","article-title":"Diverse functions of myeloid-derived suppressor cells in autoimmune diseases","volume":"72","author":"Xiong","year":"2024","journal-title":"Immunol Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/TP.0000000000002022","article-title":"Myeloid-Derived suppressor cells and their potential application in transplantation","volume":"102","author":"Scalea","year":"2018","journal-title":"Transplantation"},{"key":"B84","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/TP.0000000000002996","article-title":"Emerging role of myeloid-derived suppressor cells in the biology of transplantation tolerance","volume":"104","author":"Shao","year":"2020","journal-title":"Transplantation"},{"key":"B85","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.4049\/jimmunol.1101512","article-title":"Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5","volume":"188","author":"Dilek","year":"2012","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/TP.0b013e318186fccd.Human","article-title":"Human inhibitory receptor ILT2 amplifies CD11b+ Gr1+ myeloid- derived suppressor cells that promote long-term survival of allografts","volume":"86","author":"Zhang","year":"2008","journal-title":"Transplantation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"14249","DOI":"10.1038\/s41598-020-71289-z","article-title":"Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo","volume":"10","author":"Cai","year":"2020","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2022.827712","article-title":"Human monocyte-derived suppressor cell supernatant induces immunoregulatory effects and mitigates xenoGvHD","volume":"13","author":"G\u00e9rard","year":"2022","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e1880046","DOI":"10.1080\/2162402X.2021.1880046","article-title":"Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect","volume":"10","author":"Janikashvili","year":"2021","journal-title":"Oncoimmunology"},{"key":"B90","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00011-019-01237-9","article-title":"Adoptive transfer of IFN-\u03b3-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathway","volume":"68","author":"Yang","year":"2019","journal-title":"Inflamm Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jcyt.2023.04.010","article-title":"Metabolic reprogramming of myeloid-derived suppressor cells in the context of organ transplantation","volume":"25","author":"Iske","year":"2023","journal-title":"Cytotherapy"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1097\/TP.0000000000005309","article-title":"Regulatory immune cell-derived exosomes: modes of action and therapeutic potential in transplantation","volume":"109","author":"Avalos-De Leon","year":"2025","journal-title":"Transplantation"},{"key":"B93","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3390\/cells13040335","article-title":"Innate lymphoid cells and their role in the immune response to infections","volume":"13","author":"Fol","year":"2024","journal-title":"Cells"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1038\/s12276-023-01022-z","article-title":"Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation","volume":"55","author":"Ryu","year":"2023","journal-title":"Exp Mol Med"},{"key":"B95","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41577-022-00704-5","article-title":"Heterogeneity of type 2 innate lymphoid cells","volume":"22","author":"Spits","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/IMR.12708","article-title":"New insights into the function, development, and plasticity of type 2 innate lymphoid cells","volume":"286","author":"Krabbendam","year":"2018","journal-title":"Immunol Rev"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.202012305","article-title":"IL -10 producing type 2 innate lymphoid cells prolong islet allograft survival","volume":"12","author":"Huang","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.650200","article-title":"IL-10-producing ILCs: molecular mechanisms and disease relevance","volume":"12","author":"Sun","year":"2021","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.ajt.2025.05.023","article-title":"Cell therapy with human interleukin 10\u2013producing ILC2s enhances islet function and inhibits allograft rejection","volume":"25","author":"Colpitts","year":"2025","journal-title":"Am J Transplant"},{"key":"B100","doi-asserted-by":"publisher","first-page":"115102","DOI":"10.1016\/j.celrep.2024.115102","article-title":"Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responses","volume":"44","author":"Reid","year":"2025","journal-title":"Cell Rep"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1038\/s41467-017-02023-z","article-title":"Alternative activation generates IL-10 producing type 2 innate lymphoid cells","volume":"8","author":"Seehus","year":"2017","journal-title":"Nat Commun"},{"key":"B102","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.ajt.2024.11.035","article-title":"Group 1 innate lymphoid cells protect liver transplants from ischemia-reperfusion injury via an interferon gamma\u2013mediated pathway","volume":"25","author":"Kojima","year":"2025","journal-title":"Am J Transplant"},{"key":"B103","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/ajt.16163","article-title":"Type 3 innate lymphoid cells are associated with a successful intestinal transplant","volume":"21","author":"Kang","year":"2021","journal-title":"Am J Transplant"},{"key":"B104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/J.COI.2005.11.007","article-title":"The function of \u03b3\u03b4 T cells in innate immunity","volume":"18","author":"Born","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/ni.3726","article-title":"IL-17+\u03b3\u03b4 T cells as kick-starters of inflammation","volume":"18","author":"Papotto","year":"2017","journal-title":"Nat Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/jid.2012.16","article-title":"\u0393 T cells augment rejection of skin grafts by enhancing cross-priming of CD8T cells to skin-derived antigen","volume":"132","author":"Rahimpour","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41581-021-00466-8","article-title":"Unconventional T cells and kidney disease","volume":"17","author":"Kaminski","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2025.1584916","article-title":"IL-17A-producing \u03b3\u03b4 T cells and classical monocytes are associated with a rapid alloimmune response following vascularized composite allotransplantation in mice","volume":"16","author":"Tajima","year":"2025","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1007\/s00018-013-1467-1","article-title":"Phenotype and regulation of immunosuppressive V\u03b42-expressing \u03b3\u03b4 T cells","volume":"71","author":"Peters","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"B110","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.intimp.2013.01.022","article-title":"Regulatory functions of \u03b3\u03b4 T cells","volume":"16","author":"Kabelitz","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u0393\u03b4 T cells: origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduct Target Ther"}],"container-title":["Frontiers in Transplantation"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1776806\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:59:38Z","timestamp":1771927178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frtra.2026.1776806\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":111,"alternative-id":["10.3389\/frtra.2026.1776806"],"URL":"https:\/\/doi.org\/10.3389\/frtra.2026.1776806","relation":{},"ISSN":["2813-2440"],"issn-type":[{"value":"2813-2440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"article-number":"1776806"}}